Skip to content
Disclosery

Hanson & Doremus Investment Management: IBD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Hanson & Doremus Investment Management on IBD, newest first. How the timeline and the estimate are built.

Hanson & Doremus Investment Management held 23,092 IBD shares at 2026-06-30 per its 13F-HR filed 2026-07-29.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 23,092 shares
    Change vs previous 13F +16,657 shares

    0.06% of the 13F portfolio, value $549,000.

    13F-HR 0001393944-26-000003 filed by Hanson & Doremus Investment Management
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 6,435 shares
    Change vs previous 13F -100 shares

    0.02% of the 13F portfolio, value $154,000.

    13F-HR 0001393944-26-000002 filed by Hanson & Doremus Investment Management
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 6,535 shares
    Change vs previous 13F +60 shares

    0.02% of the 13F portfolio, value $158,000.

    13F-HR 0001393944-26-000001 filed by Hanson & Doremus Investment Management
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 6,475 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $156,000.

    13F-HR 0001393944-25-000008 filed by Hanson & Doremus Investment Management
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).